Elevation Oncology Inc – To Prepay Term Loan Under Loan & Security Agreement Dated July 27, 2022 – SEC Filing – Market News Board

Market Closed – Nasdaq			5-day change	1st Jan Change
0.2500 ^USD	-3.29%		-3.88%	-55.56%

April 04, 2025 at 05:59 pm EDT

This article is reserved for members

Unlock the article: REGISTER NOW!

Elevation Oncology Inc – To Prepay Term Loan Under Loan & Security Agreement Dated July 27, 2022 – SEC Filing	Apr. 04	RE
Stephens Downgrades Elevation Oncology to Equal Weight From Overweight, Adjusts Price Target to $1 From $5	Mar. 24	MT
Wedbush Downgrades Elevation Oncology to Neutral From Outperform, Cuts Price Target to $1.60 From $5	Mar. 21	MT
Leerink Downgrades Elevation Oncology to Market Perform From Outperform, Adjusts Price Target to $1 From $9	Mar. 21	MT
Piper Sandler Downgrades Elevation Oncology to Neutral From Overweight, Adjusts Price Target to $0.70 From $10	Mar. 21	MT
Sector Update: Health Care Stocks Decline Pre-Bell Thursday	Mar. 20	MT
Elevation Oncology Drops Potential Metastatic Cancer Drug, Evaluates Strategic Options; Shares Fall Pre-Bell	Mar. 20	MT
Elevation Oncology, Inc. to Discontinue Development of EO-3021	Mar. 20	CI
Elevation Oncology, Inc. Announces Step Down of Valerie M. Jansen as Chief Medical Officer, Effective March 31, 2025	Mar. 20	CI
Elevation Oncology, Inc. Implements A Workforce Reduction of Approximately 70%	Mar. 20	CI
Elevation Oncology Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Business Achievements	Mar. 06	RE
Elevation Oncology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2024	Mar. 06	CI
Aadi Bioscience Appoints David Dornan, Phd, as Chief Scientific Officer	Feb. 18	CI
Elevation Oncology, Inc. Announces Resignation of David Dornan as Chief Scientific Officer, Effective February 17, 2025	Jan. 31	CI
Elevation Oncology Advances EO-3021 and EO-1022 ADC Programs with Promising Phase 1 Data and Upcoming Milestones	Jan. 13	CI
William Blair Initiates Elevation Oncology at Outperform	Jan. 03	MT
Elevation Oncology, Inc. Expands Pipeline with Nomination of EO-1022, a HER3 ADC for the Treatment of HER3-Expressing Solid Tumors	Dec. 12	CI
Elevation Oncology, Inc. Presents Preclinical Proof-Of-Concept Data Supporting Combination Potential of Eo-3021 with Vegfr2 or Pd-1 Inhibitors At Esmo Immuno-Oncology Annual Congress 2024	Dec. 05	CI
Earnings Flash (ELEV) ELEVATION ONCOLOGY Posts Q3 Loss $-0.22	Nov. 06	MT
Elevation Oncology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	Nov. 06	CI
Elevation Oncology Gets FDA Fast-Track Designation for EO-3021	24-09-23	DJ
Elevation Oncology, Inc.(NasdaqGS:ELEV) added to S&P Global BMI Index	24-09-22	CI
Affimed N.V. Announces Chief Executive Officer Changes	24-09-03	CI
Elevation Oncology, Inc. – Special Call	24-08-06
Elevation Oncology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	24-08-06	CI

Duration

Period

ELEV: Dynamic Chart

Elevation Oncology, Inc. is an oncology company. The Company is focused on the discovery and development of selective cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs. Its lead product candidate, EO-3021 is an antibody-drug conjugate (ADC) designed to target Claudin 18.2, which can selectively deliver a cytotoxic payload directly to cancer cells expressing Claudin 18.2. EO-3021 consists of a fully human immunoglobulin G1 (IgG1) mAb that targets Claudin 18.2 and is site-specifically conjugated to the monomethyl auristatin E (MMAE) payload via a cleavable linker with a drug-to-antibody ratio (DAR) of 2. EO-3021 is designed to bind to Claudin 18.2 on the cell surface and is internalized, upon which the linker is cleaved in the lysosome to release the MMAE payload, a potent anti-mitotic agent. Its second program is an ADC designed to target HER3, which is overexpressed across solid tumors.

More about the company

Sell

Buy

Last Close Price

0.2585USD

Average target price

1.060USD

Spread / Average Target

+310.06%

Consensus

Exclusive-US Health Secretary Kennedy to address Gavi vaccine event amid funding pullback

Tesla seeks to keep Texas robotaxi data under wraps, regulator says

Oil prices are now the stock market’s biggest driver

Tesla shares soar after first robotaxi rides hit the road in Austin, Texas

Fed’s Bowman open to cutting rates at July policy meeting

Fiserv shares rise on stablecoin launch plans

Top Premarket Decliners | MarketScreener

Commercial Metals misses Q3 revenue estimates

Amazon’s premium beauty push may be a buffer against Trump’s tariffs

Ethereum’s ‘Identity Crisis’ Is What Real Decentralization Looks Like

Bitcoin Chases Range Highs While Altcoins Struggle

US Regulator Mulls Crypto Mortgages Amid Housing Crisis

SoFi Is Getting Back Into Crypto, Starting With Bitcoin and Ethereum

Bitcoin Exchange Flows Drop to 10-year Lows as Traders Eye $165K BTC Price

Ethereum ‘Death Cross’ Flashes For The First Time Since 2022 ETH Price Sell-off

Exclusive-US Health Secretary Kennedy to address Gavi vaccine event amid funding pullback

Tesla seeks to keep Texas robotaxi data under wraps, regulator says

Oil prices are now the stock market’s biggest driver

Tesla shares soar after first robotaxi rides hit the road in Austin, Texas

Fed’s Bowman open to cutting rates at July policy meeting

Fiserv shares rise on stablecoin launch plans

Top Premarket Decliners | MarketScreener

Commercial Metals misses Q3 revenue estimates

Amazon’s premium beauty push may be a buffer against Trump’s tariffs

Ethereum’s ‘Identity Crisis’ Is What Real Decentralization Looks Like

Bitcoin Chases Range Highs While Altcoins Struggle

US Regulator Mulls Crypto Mortgages Amid Housing Crisis

SoFi Is Getting Back Into Crypto, Starting With Bitcoin and Ethereum

Bitcoin Exchange Flows Drop to 10-year Lows as Traders Eye $165K BTC Price

Ethereum ‘Death Cross’ Flashes For The First Time Since 2022 ETH Price Sell-off

Elevation Oncology Inc – To Prepay Term Loan Under Loan & Security Agreement Dated July 27, 2022 – SEC Filing

Related Posts

Ethereum’s ‘Identity Crisis’ Is What Real Decentralization Looks Like

Bitcoin Chases Range Highs While Altcoins Struggle

Stocks mixed midday, Powell speaks again, Tesla shares skid

Forexlive Americas FX news wrap 4 Apr; Better US jobs don't help markets. Stocks tumble

The Future Of Bitcoin Mining Is Distributed

Feeling queasy about the stock market? Think twice before selling, financial advisers say

Recent Posts

Navigate Site

Elevation Oncology Inc – To Prepay Term Loan Under Loan & Security Agreement Dated July 27, 2022 – SEC Filing

Related Posts

Recent Posts

Navigate Site

Follow Us